🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Congratulations Sírio-Libanês and Memorial Sloan Kettering Cancer Center for a continued robust relationship. MSK Department of Medicine Yelena Y. Janjigian MD Eileen M O’Reilly Ghassan Abou-Alfa and others are greatly honored and delighted to have contributed over the two days!

This Wednesday we will go deeply into discussions about #ArtificialInteligence in #prostatecancer and real-life cases. Practical and important topics. 👉08/30/23 ⏰7:30 pm (GMT-3). Rafael Coelho Diogo Assed Bastos Milena Tariki

Looking forward to 2024 Advanced #ProstateCancer Consensus Conference (APCCC) in Lugano, Switzerland 👇 Registration and information link👉 apccc.org Scientific program link👉 tinyurl.com/442vzhkj silke gillessen aurelius omlin PCF Science UroToday.com OncoAlert

The new study LACOG 0723-ADRENAL PROJECT is a retrospective cohort study that aims to characterize a cohort of patients with adrenocortical carcinoma regarding clinical, pathological, epidemiological and molecular aspects. This is the first study fully funded by LACOG GU Group.

🚀 Elevate the Consenus at #APCCC24! 🌟 Engage, Debate, Shape Future Guidelines! 🔗 Meet the Panel & Join Us → bit.ly/46i3Hao #ProstateCancer #Oncology #CancerResearch #MedicalConference #ClinicalConsensus #APCCC

Join us for the GU highlights of #ESMO2023. Practical and important topics with great superstars discussing. 👉10/25/23 ⏰7:30 pm (GMT-3) Felipe de Galiza Daniel Vargas Pivato de Almeida Diogo Assed Bastos Rafael Coelho @DocMeetings - Urology DocMeetings_Oncology uropratica.com.br -online and free

2023 is almost over! A wrap-up of the most important and practice changing data in GU tumors (urology, medonc, radiology, rdt) 👉11/29/23 ⏰7:30 pm (GMT-3) Publio Viana Diogo Assed Bastos Rafael Coelho @DocMeetings - Urology DocMeetings_Oncology uropratica.com.br -online and free

Prostate cancers with combined BRCA2 and SPOP mutations have greater homologous repair deficiency and increased sensitivity to PARP inhibitors. This is a clinically actionable patient subset! Congrats to our collaborators from 13 centers. sciencedirect.com/science/articl…

An amazing opportunity to learn about prostate cancer is APCCC 2024 in beautiful Lugano! Register here apccc.org Advanced Prostate Cancer Consensus Conference silke gillessen aurelius omlin Dana-Farber Lank Center for Genitourinary Oncology

✨ The Advanced Prostate Cancer Consensus Conference (APCCC) 2024 is fast approaching, and we're thrilled to unveil our panel of esteemed global experts! 🌐 Meet the panel shaping the future of prostate cancer care! Join us at #APCCC24 for unparalleled insights and collaborative

🌟 Be part of a pivotal moment in advanced #prostatecancer managment at #APCCC24! Join global experts in consensus discussions that shape future treatments. 🗓️ Register now for an unmissable experience: apccc.org #Oncology #GU24 #oncoalert

🌟 Be part of a pivotal moment in advanced #prostatecancer managment at #APCCC24! Join global experts in consensus discussions that shape future treatments. 🗓️ Register now for an unmissable experience: apccc.org #Oncology #GU24 #oncoalert

Day 2 of #APCCC24 has wrapped, marking another fantastic chapter in advancing prostate cancer care. We celebrate the wealth of knowledge exchanged and the consensus achieved on many pressing questions in advanced prostate cancer management. 🔬 Vital discussions have paved the

Probably an outdated discussion, but our randomized trial Open versus RARP was finally published. A Herculean effort that started 10 years ago

After Radicals-HD there is still a lot of questions about adding ADT to salvage Rtx Join us for this multidisciplinary debate 👉07/10/24 ⏰7:30 pm (GMT-3) Register online and free at uropratica.com.br Rafael Coelho Diogo Assed Bastos Fernando Sabino, MD, PhD Mauricio Zapparoli, MD MSc @DocMeetings - Urology

A great Pleasure to Present our paper on Management of patients with Advanced #ProstateCancer : A Report from #APCCC24 LINK TO ARTICLE👇👇👇👇👇👇👇👇 sciencedirect.com/science/articl… The 2024 Advanced Prostate Cancer Consensus Conference (APCCC) highlights significant advances in

In patients with localized #ProstateCancer who are clinically staged as T2 based on digital rectal examination cN0 cM0 and ISUP GG ≥3 carcinoma and clear evidence of T3 disease on MRI Link:sciencedirect.com/science/articl… The consensus at Advanced Prostate Cancer Consensus Conference 2024 was overwhelmingly in favor

No Better way to start 2025 A great Pleasure to Present our paper on Management of patients with Advanced #ProstateCancer A Report from #APCCC24 LINK TO ARTICLE👇👇👇 sciencedirect.com/science/articl… The 2024 Advanced Prostate Cancer Consensus Conference (APCCC) highlights significant

Management of patients with Advanced #ProstateCancer : A Report from #APCCC24 LINK TO ARTICLE👇👇 sciencedirect.com/science/articl… The 2024 Advanced Prostate Cancer Consensus Conference (APCCC) highlights significant advances in prostate cancer management while underscoring areas where